Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL68148 | 0.79 | ALDH1A1 (0.59) | ALDH1A1CES2CES1TSHRTP53 | |
| SCHEMBL20587670 | 0.79 | ALDH1A1 (0.59) | ALDH1A1CES2CES1TSHRTP53 | |
| SCHEMBL8141436 | 0.78 | TSHR (0.60) | ALDH1A1CES2CES1TSHRTP53 | |
| SCHEMBL1106586 | 0.76 | PARP10 (0.48) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL838030 | 0.76 | MAPT (0.48) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL28787222 | 0.76 | ALDH1A1 (0.56) | ALDH1A1CES2CES1TSHRTP53 | |
| Ammonia Solution, Strong SCHEMBL2023211 | 0.76 | ALDH1A1 (0.56) | ALDH1A1CES2CES1TSHRTP53 | |
| SCHEMBL6758498 | 0.76 | ALDH1A1 (0.64) | ALDH1A1CES2CES1TSHRTP53 | |
| Hydrochloric Acid SCHEMBL2362644 | 0.76 | ALDH1A1 (0.56) | ALDH1A1CES2CES1TSHRTP53 | |
| Hydrogen Sulfide SCHEMBL10896015 | 0.76 | ALDH1A1 (0.56) | ALDH1A1CES2CES1TSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119391082-B | High-strength stamping-resistant PP composite material and preparation method thereof | 普宁市齐毫文具有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-120059126-A | Thermal insulation composite material and preparation method and application thereof | 成都昭管武科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119391082-A | High-strength stamping-resistant PP composite material and preparation method thereof | 普宁市齐毫文具有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-118772518-B | Cable composite material with halogen-free flame retardant function and preparation method thereof | 廊坊集瑞高分子材料有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-119161269-A | Continuous production technology of butanone oxime and acetaldehyde oxime | 浙江锦华新材料股份有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-119144029-A | Biodegradable environment-friendly food preservative film and manufacturing method thereof | 苏州汉德瑞生物工程有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118772518-A | Cable composite material with halogen-free flame retardant function and preparation method thereof | 廊坊集瑞高分子材料有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-120775464-B | Corrosion-resistant coating and application thereof in aluminum alloy heat exchange tube | 安陆火凤凰铝材有限责任公司 | 2025-11-18 | — | — | CN | disclosed |
| CN-120775464-A | Corrosion-resistant coating and application thereof in aluminum alloy heat exchange tube | 安陆火凤凰铝材有限责任公司 | 2025-10-14 | — | — | CN | disclosed |
| CN-120059126-A | Thermal insulation composite material and preparation method and application thereof | 成都昭管武科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-118772518-B | Cable composite material with halogen-free flame retardant function and preparation method thereof | 廊坊集瑞高分子材料有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-119161269-A | Continuous production technology of butanone oxime and acetaldehyde oxime | 浙江锦华新材料股份有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-119161269-A | Continuous production technology of butanone oxime and acetaldehyde oxime | 浙江锦华新材料股份有限公司 | 2024-12-20 | — | — | CN | disclosed |
| US-20070293442-A1 | ANTITHROMBOTIC COMPOUND | SANOFI-AVENTIS (FR) | 2007-12-20 | — | — | US | disclosed |
| US-7285565-B2 | Benzamides and related inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-10-23 | — | — | US | disclosed |
| US-7262223-B2 | Amidine derivatives for treating amyloidosis | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-08-28 | — | — | US | disclosed |
| US-20070112039-A1 | Better thermal and hydrolytic stability than the free-base compounds; N-(5-chloro-pyridin-2-yl)-2-(4-cyano-benzoyl-amino)-5-methoxy-benzamide Hydrochloride | MILLENNIUM PHARMACEUTICALS, INC. | 2007-05-17 | — | — | US | disclosed |
| US-20070021472-A1 | N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility | MILLENNIUM PHARMACEUTICALS, INC. | 2007-01-25 | — | — | US | disclosed |
| US-20070021483-A1 | Amidine derivatives for treating amyloidosis | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-01-25 | — | — | US | disclosed |
| US-4155937-A | BENZOYL PEROXIDES WITH REACTIVE SUBSTITUENTS, TELECHELIC POLYMERS | POLAROID CORPORATION (US) | 1979-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112039-A1 | Better thermal and hydrolytic stability than the free-base compounds; N-(5-chloro-pyridin-2-yl)-2-(4-cyano-benzoyl-amino)-5-methoxy-benzamide Hydrochloride | F12, CMA1, F11 | ALDH1A1 830/4885HDAC3 526/4885HDAC4 547/4885 |
| US-20070293442-A1 | ANTITHROMBOTIC COMPOUND | F13B, SERPINC1, SELP | ALDH1A1 1008/4885HDAC3 497/4885HDAC4 1117/4885 |
| US-20070021472-A1 | N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility | F2, TFPI, PLG | ALDH1A1 1661/4885HDAC3 148/4885HDAC4 778/4885 |
| US-20070021483-A1 | Amidine derivatives for treating amyloidosis | APP, IAPP, GRN | ALDH1A1 2283/4885HDAC3 3707/4885HDAC4 3196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.